3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
6
Thoracic
4
Head & Neck
4
Gastrointestinal
4
Dermatologic
4
Gynecologic
3
Breast
3
Lymphoid
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Endocrine
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
4
Myeloproliferative Disorders
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Congenital Abnormalities
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Interventions
fludarabine phosphate
4
Cyclophosphamide
4
Antilymphocyte Serum
4
Mycophenolic Acid
3
Filgrastim
3
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Cyclosporine
2
Busulfan
2
thymoglobulin
1
sargramostim
1
ixabepilone
1
fludarabine
1
cc-486
1
aldesleukin
1
Whole-Body Irradiation
1
Voriconazole
1
Stem Cell Transplantation
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Interleukin-12 Subunit p35
1
Interferon-alpha
1
Injections
1
Immunotherapy
1
Granulocyte Colony-Stimulating Factor
1
Drug Therapy
1
Cord Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Drug Therapy
×
Myeloid
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled